Use of single-dose tocilizumab for treatment of severe COVID-19 in pregnancy: implications for the timing of live infant vaccines.

Saved in:
Bibliographic Details
Title: Use of single-dose tocilizumab for treatment of severe COVID-19 in pregnancy: implications for the timing of live infant vaccines.
Authors: Burkhardt I; Children's Services, Imperial College Healthcare NHS Trust, London, UK burkhardt.ingrid@gmail.com., Whittaker E; Paediatrics, Imperial College Healthcare NHS Trust, London, UK.
Source: Archives of disease in childhood [Arch Dis Child] 2022 May; Vol. 107 (5), pp. 517. Date of Electronic Publication: 2022 Feb 03.
Publication Type: Letter
Journal Info: Publisher: BMJ Pub. Group [etc.] Country of Publication: England NLM ID: 0372434 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2044 (Electronic) Linking ISSN: 00039888 NLM ISO Abbreviation: Arch Dis Child Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2044
DOI:10.1136/archdischild-2021-323628